• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges.

作者信息

Schlenk Richard F

机构信息

NCT-Trial Center, National Center for Tumor Diseases, German Cancer Research Center and Heidelberg University Hospital; Department of Hematology, Oncology, and Rheumatology at Heidelberg University Hospital, University of Heidelberg, Heidelberg.

出版信息

Haematologica. 2023 Feb 1;108(2):306-307. doi: 10.3324/haematol.2022.280803.

DOI:10.3324/haematol.2022.280803
PMID:36722401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9890027/
Abstract
摘要

相似文献

1
Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges.急性髓系白血病：聚焦进展与持续挑战系列介绍
Haematologica. 2023 Feb 1;108(2):306-307. doi: 10.3324/haematol.2022.280803.
2
[Leukemia: recent progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 1. Treatment for adult acute myeloid leukemia].[白血病：诊断与治疗的最新进展。主题：三、诊断与治疗；1. 成人急性髓系白血病的治疗]
Nihon Naika Gakkai Zasshi. 2013 Jul 10;102(7):1687-95. doi: 10.2169/naika.102.1687.
3
The evolving paradigm of prognostic factors in AML: Introduction to the Acute Leukemia Forum 2010.急性髓系白血病预后因素的演变模式：2010年急性白血病论坛介绍
Best Pract Res Clin Haematol. 2010 Dec;23(4):453-6. doi: 10.1016/j.beha.2010.09.007. Epub 2010 Nov 4.
4
Recent progress in acute leukemia and myelodysplasia.急性白血病和骨髓增生异常综合征的最新进展。
Best Pract Res Clin Haematol. 2022 Dec;35(4):101415. doi: 10.1016/j.beha.2022.101415. Epub 2022 Nov 14.
5
Clinical implications of molecular markers in acute myeloid leukemia.急性髓细胞白血病中分子标志物的临床意义。
Eur J Haematol. 2019 Jan;102(1):20-35. doi: 10.1111/ejh.13172. Epub 2018 Oct 23.
6
Progress in acute myeloid leukemia.急性髓系白血病的进展
Clin Lymphoma Myeloma Leuk. 2015 Mar;15(3):139-51. doi: 10.1016/j.clml.2014.08.006. Epub 2014 Sep 19.
7
Isolated Mediastinal Myeloid Sarcoma after -Positive Pediatric Acute Myeloid Leukemia.小儿急性髓系白血病阳性后孤立性纵隔髓系肉瘤
Turk J Haematol. 2019 Nov 18;36(4):285-286. doi: 10.4274/tjh.galenos.2019.2018.0434. Epub 2019 Mar 12.
8
SnapShot: Acute myeloid leukemia.简讯：急性髓系白血病
Cancer Cell. 2012 Nov 13;22(5):698-698.e1. doi: 10.1016/j.ccr.2012.10.017.
9
[Prognostic factors and therapeutic strategies for acute myeloid leukemia].[急性髓系白血病的预后因素及治疗策略]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 May;39(3):221-5. doi: 10.3785/j.issn.1008-9292.2010.03.001.
10
Acute myeloid leukemia in the elderly.老年急性髓系白血病
Med Health R I. 2011 Jan;94(1):7-9.

引用本文的文献

1
Comparative efficacy and safety in low-intensity treatment for acute myeloid leukemia in older patients: a systematic review and network meta-analysis.老年急性髓系白血病低强度治疗的比较疗效与安全性：一项系统评价和网状Meta分析
Eur J Med Res. 2025 Apr 15;30(1):280. doi: 10.1186/s40001-025-02476-9.
2
CX43-mediated mitochondrial transfer maintains stemness of KG-1a leukemia stem cells through metabolic remodeling.CX43介导的线粒体转移通过代谢重塑维持KG-1a白血病干细胞的干性。
Stem Cell Res Ther. 2024 Dec 2;15(1):460. doi: 10.1186/s13287-024-04079-3.
3
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML.基于维奈托克的挽救性治疗作为移植的桥梁，对于复发/难治性急性髓系白血病患者是可行且有效的。
Blood Adv. 2025 Jan 28;9(2):375-385. doi: 10.1182/bloodadvances.2024013086.
4
A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy.一种双特异性纳米系统激活骨髓中的内源性自然杀伤细胞用于血液系统恶性肿瘤治疗。
Nat Nanotechnol. 2024 Oct;19(10):1558-1568. doi: 10.1038/s41565-024-01736-9. Epub 2024 Jul 23.
5
Interleukin-2 mediated associations between gut microbiota and acute myeloid leukemia: A population-based mediation Mendelian randomization study.白细胞介素-2介导的肠道微生物群与急性髓系白血病之间的关联：一项基于人群的中介孟德尔随机化研究
Heliyon. 2024 Jun 17;10(12):e33194. doi: 10.1016/j.heliyon.2024.e33194. eCollection 2024 Jun 30.

本文引用的文献

1
Leukemic stem cells and therapy resistance in acute myeloid leukemia.急性髓系白血病中的白血病干细胞与治疗耐药性。
Haematologica. 2023 Feb 1;108(2):353-366. doi: 10.3324/haematol.2022.280800.
2
Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question.成人急性髓系白血病当前治疗方法的更新：强化治疗还是非强化治疗？这是个问题。
Haematologica. 2023 Feb 1;108(2):342-352. doi: 10.3324/haematol.2022.280802.
3
New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia.造血干细胞移植前后新药物治疗急性髓细胞白血病患者。
Haematologica. 2023 Feb 1;108(2):321-341. doi: 10.3324/haematol.2022.280798.
4
The clinical impact of the molecular landscape of acute myeloid leukemia.急性髓系白血病分子特征的临床影响。
Haematologica. 2023 Feb 1;108(2):308-320. doi: 10.3324/haematol.2022.280801.
5
Radical surgery and venetoclax plus azacitidine in an octogenarian with acute myeloid leukemia.一名八旬急性髓系白血病患者的根治性手术及维奈克拉联合阿扎胞苷治疗
Haematologica. 2023 Jul 1;108(7):1965-1967. doi: 10.3324/haematol.2022.282282.
6
Leon's helmet.利昂的头盔。
Haematologica. 2023 May 1;108(5):1450-1451. doi: 10.3324/haematol.2022.281125.
7
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.成人 AML 的诊断与治疗：ELN 专家组代表发布的 2022 年国际专家建议
Blood. 2022 Sep 22;140(12):1345-1377. doi: 10.1182/blood.2022016867.
8
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.阿扎胞苷和维奈托克治疗未经治急性髓系白血病。
N Engl J Med. 2020 Aug 13;383(7):617-629. doi: 10.1056/NEJMoa2012971.
9
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.阿扎胞苷对比传统治疗方案用于新诊断的原始细胞比例>30%的老年急性髓系白血病患者的国际3期研究。
Blood. 2015 Jul 16;126(3):291-9. doi: 10.1182/blood-2015-01-621664. Epub 2015 May 18.
10
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.多中心、随机、开放标签、III 期临床试验，比较地西他滨与患者选择的支持治疗或低剂量阿糖胞苷治疗新诊断的老年急性髓系白血病，患者选择方案由医生提供建议。
J Clin Oncol. 2012 Jul 20;30(21):2670-7. doi: 10.1200/JCO.2011.38.9429. Epub 2012 Jun 11.